Symbols / HR Stock $18.71 +0.65% Healthcare Realty Trust Incorporated

Real Estate • REIT - Healthcare Facilities • United States • NYQ
HR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Real Estate
Industry REIT - Healthcare Facilities
CEO Mr. Peter A. Scott
Exch · Country NYQ · United States
Market Cap 6.48B
Enterprise Value 10.71B
Income -248.48M
Sales 1.18B
FCF (ttm) 107.20M
Book/sh 13.13
Cash/sh 0.07
Employees 539
Insider 10d
IPO May 27, 1993
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 251.53%
P/E
Forward P/E -187.10
PEG 8.82
P/S 5.49
P/B 1.42
P/C
EV/EBITDA 15.22
EV/Sales 9.07
Quick Ratio 0.24
Current Ratio 0.73
Debt/Eq 88.77
LT Debt/Eq
EPS (ttm) -0.71
EPS next Y -0.10
EPS Growth
Revenue Growth -7.80%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-12
ROA 0.58%
ROE -5.00%
ROIC
Gross Margin 61.78%
Oper. Margin 11.71%
Profit Margin -20.85%
Shs Outstand 346.53M
Shs Float 344.76M
Insider Own 0.58%
Instit Own 117.00%
Short Float 8.91%
Short Ratio 5.35
Short Interest 17.00M
52W High 18.97
vs 52W High -1.37%
52W Low 14.09
vs 52W Low 32.79%
Beta 0.80
Impl. Vol. 55.66%
Rel Volume 0.95
Avg Volume 3.60M
Volume 3.41M
Target (mean) $19.18
Tgt Median $19.00
Tgt Low $18.00
Tgt High $21.00
# Analysts 11
Recom Hold
Prev Close $18.59
Price $18.71
Change 0.65%
About

Healthcare Realty Trust Incorporatedis a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt less cash. Healthcare Realty Trust Incorporated was incorporated in 1992 in Maryland, USA.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$18.71
Low
$18.00
High
$21.00
Mean
$19.18

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 init UBS — → Neutral $18
2026-02-17 main Cantor Fitzgerald Overweight → Overweight $21
2025-11-25 main Wells Fargo Equal-Weight → Equal-Weight $19
2025-11-12 main Citigroup Neutral → Neutral $19
2025-10-20 up Wells Fargo Underweight → Equal-Weight $18
2025-10-01 init Cantor Fitzgerald — → Overweight $23
2025-09-29 reit BTIG Buy → Buy $20
2025-09-15 down Raymond James Market Perform → Underperform
2025-09-10 reit BTIG Buy → Buy $20
2025-09-05 up Scotiabank Sector Perform → Sector Outperform $20
2025-08-28 main Scotiabank Sector Perform → Sector Perform $18
2025-08-27 main Wells Fargo Underweight → Underweight $16
2025-06-26 main JP Morgan Neutral → Neutral $17
2025-06-02 main Wells Fargo Underweight → Underweight $15
2025-05-05 main Wedbush Neutral → Neutral $16
2025-03-10 main Wells Fargo Underweight → Underweight $16
2025-02-25 main Scotiabank Sector Perform → Sector Perform $17
2025-01-02 down Wedbush Neutral → Underperform $16
2024-12-20 down JP Morgan Overweight → Neutral $19
2024-08-07 main Scotiabank Sector Perform → Sector Perform $18
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 BOHJALIAN THOMAS N Director 10,000 $18.09 $180,900
2026-03-04 GABBAY DANIEL Chief Financial Officer 10 $18.74 $187
2026-02-09 CALLAWAY AMANDA L Officer 34,689 $17.13 $594,223
2026-02-09 HULL ROBERT E Chief Operating Officer 33,859 $17.13 $580,005
2026-02-09 SCOTT PETER A Chief Executive Officer 155,867 $17.13 $2,670,002
2026-02-09 CROWLEY RYAN E. Chief Investment Officer 32,788 $17.13 $561,658
2026-02-09 LOOPE ANDREW E. General Counsel 32,588 $17.13 $558,232
2026-02-09 GABBAY DANIEL Chief Financial Officer 191,158 $17.13 $3,299,985
2025-12-31 SCOTT PETER A Chief Executive Officer 6,640 $16.94 $112,482
2025-12-31 CROWLEY RYAN E. Chief Investment Officer 5,844 $16.94 $98,997
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,152.33
-7.75%
1,249.16
-5.82%
1,326.32
+44.33%
918.93
Operating Revenue
1,152.33
-7.75%
1,249.16
-5.82%
1,326.32
+44.33%
918.93
Cost Of Revenue
449.07
-5.15%
473.44
-5.39%
500.44
+45.46%
344.04
Reconciled Cost Of Revenue
401.87
-5.73%
426.28
-6.36%
455.26
+42.56%
319.34
Gross Profit
703.26
-9.34%
775.72
-6.07%
825.88
+43.66%
574.89
Operating Expense
608.32
-17.70%
739.12
-4.22%
771.66
+56.81%
492.11
Selling General And Administration
72.57
-12.69%
83.12
+42.32%
58.41
+10.75%
52.73
General And Administrative Expense
72.57
-12.69%
83.12
+42.32%
58.41
+10.75%
52.73
Other Gand A
72.57
-12.69%
83.12
+42.32%
58.41
+10.75%
52.73
Other Operating Expenses
-28.21
-47.28%
-19.16
-9.78%
-17.45
-27.32%
-13.71
Total Expenses
1,057.39
-12.80%
1,212.56
-4.68%
1,272.10
+52.14%
836.15
Operating Income
94.94
+159.40%
36.60
-32.50%
54.22
-34.51%
82.78
EBITDA
568.99
+92.52%
295.55
-60.72%
752.39
+12.85%
666.71
Normalized EBITDA
701.15
-7.01%
754.01
-9.13%
829.77
+48.21%
559.87
Reconciled Depreciation
611.17
-15.39%
722.32
-6.90%
775.89
+62.40%
477.78
EBIT
-42.18
+90.12%
-426.77
-1716.12%
-23.50
-112.44%
188.93
Total Unusual Items
-132.17
+71.17%
-458.46
-492.50%
-77.38
-172.43%
106.83
Total Unusual Items Excluding Goodwill
-132.17
+71.17%
-458.46
-492.50%
-77.38
-172.43%
106.83
Special Income Charges
-367.08
+35.31%
-567.44
-266.27%
-154.92
+5.21%
-163.44
Other Special Charges
0.45
+90.30%
0.24
+482.26%
-0.06
-102.58%
2.40
Impairment Of Capital Assets
364.60
-35.36%
564.08
+264.13%
154.91
+184.62%
54.43
Restructuring And Mergern Acquisition
2.03
-35.01%
3.12
+4118.92%
0.07
-99.93%
106.61
Net Income
-246.07
+62.40%
-654.49
-135.21%
-278.26
-780.39%
40.90
Pretax Income
-249.49
+62.42%
-663.90
-135.36%
-282.08
-793.20%
40.69
Net Non Operating Interest Income Expense
-212.06
+12.34%
-241.90
+5.96%
-257.24
-73.53%
-148.24
Interest Expense Non Operating
207.30
-12.58%
237.13
-8.30%
258.58
+74.44%
148.24
Net Interest Income
-212.06
+12.34%
-241.90
+5.96%
-257.24
-73.53%
-148.24
Interest Expense
207.30
-12.58%
237.13
-8.30%
258.58
+74.44%
148.24
Interest Income Non Operating
1.34
Interest Income
1.34
Other Income Expense
-132.36
+71.14%
-458.60
-480.07%
-79.06
-174.48%
106.15
Gain On Sale Of Security
234.91
+115.57%
108.97
+40.52%
77.55
-71.31%
270.27
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
22.44
Net Income Including Noncontrolling Interests
-249.49
+62.42%
-663.90
-135.36%
-282.08
-793.20%
40.69
Net Income From Continuing Operation Net Minority Interest
-246.07
+62.40%
-654.49
-135.21%
-278.26
-780.39%
40.90
Net Income From Continuing And Discontinued Operation
-246.07
+62.40%
-654.49
-135.21%
-278.26
-780.39%
40.90
Net Income Continuous Operations
-249.49
+62.42%
-663.90
-135.36%
-282.08
-793.20%
40.69
Minority Interests
3.41
-63.75%
9.42
+146.44%
3.82
+1773.53%
0.20
Normalized Income
-113.90
+41.89%
-196.02
+2.42%
-200.88
-361.78%
-43.50
Net Income Common Stockholders
-248.48
+62.37%
-660.40
-134.51%
-281.62
-832.23%
38.46
Otherunder Preferred Stock Dividend
2.41
-59.29%
5.92
+76.45%
3.35
+37.67%
2.44
Diluted EPS
-0.71
+60.77%
-1.81
-144.59%
-0.74
-593.33%
0.15
Basic EPS
-0.71
+60.83%
-1.81
-144.59%
-0.74
-593.33%
0.15
Basic Average Shares
349.80
-4.31%
365.55
-3.53%
378.93
+50.16%
252.36
Diluted Average Shares
349.80
-4.31%
365.55
-3.53%
378.93
+49.26%
253.87
Diluted NI Availto Com Stockholders
-248.48
+62.37%
-660.40
-134.51%
-281.62
-830.69%
38.54
Average Dilution Earnings
0.00
0.00
-100.00%
0.08
Depreciation Amortization Depletion Income Statement
563.97
-16.47%
675.15
-7.60%
730.71
+61.28%
453.08
Depreciation And Amortization In Income Statement
563.97
-16.47%
675.15
-7.60%
730.71
+61.28%
453.08
Earnings From Equity Interest
-0.19
-39.26%
-0.14
+91.97%
-1.68
-144.83%
-0.69
Total Other Finance Cost
4.76
-0.19%
4.77
-14.66%
5.59
+31.30%
4.26
Line Item Trend 2023-12-31
Total Assets
12,637.13
Current Assets
504.67
Cash Cash Equivalents And Short Term Investments
25.70
Cash And Cash Equivalents
25.70
Receivables
353.68
Accounts Receivable
180.07
Gross Accounts Receivable
188.47
Allowance For Doubtful Accounts Receivable
-8.40
Other Receivables
Prepaid Assets
116.45
Assets Held For Sale Current
8.83
Total Non Current Assets
12,132.43
Net PPE
275.98
Gross PPE
275.98
Other Properties
275.98
Goodwill And Other Intangible Assets
318.26
Goodwill
250.50
Other Intangible Assets
67.76
Investments And Advances
319.63
Long Term Equity Investment
311.51
Other Investments
2.11
Other Non Current Assets
41.71
Total Liabilities Net Minority Interest
5,714.35
Current Liabilities
562.09
Payables And Accrued Expenses
211.99
Payables
Accounts Payable
Other Payable
Current Accrued Expenses
Total Tax Payable
Current Debt And Capital Lease Obligation
349.80
Current Debt
349.80
Current Deferred Liabilities
Current Deferred Revenue
Other Current Liabilities
0.29
Total Non Current Liabilities Net Minority Interest
5,152.26
Long Term Debt And Capital Lease Obligation
4,949.28
Long Term Debt
4,645.06
Long Term Capital Lease Obligation
304.22
Other Non Current Liabilities
202.98
Preferred Securities Outside Stock Equity
3.87
Stockholders Equity
6,822.66
Common Stock Equity
6,822.66
Capital Stock
3.81
Common Stock
3.81
Preferred Stock
0.00
Share Issued
380.96
Ordinary Shares Number
380.96
Treasury Shares Number
0.00
Additional Paid In Capital
9,602.59
Retained Earnings
1,028.79
Gains Losses Not Affecting Retained Earnings
-10.74
Minority Interest
100.12
Other Equity Adjustments
-10.74
Total Equity Gross Minority Interest
6,922.78
Total Capitalization
11,467.72
Working Capital
-57.42
Invested Capital
11,817.52
Total Debt
5,299.08
Net Debt
4,969.16
Capital Lease Obligations
304.22
Net Tangible Assets
6,504.40
Tangible Book Value
6,504.40
Available For Sale Securities
6.01
Derivative Product Liabilities
Financial Assets
4.63
Interest Payable
Investment Properties
11,172.21
Investmentin Financial Assets
6.01
Investmentsin Joint Venturesat Cost
311.51
Line Of Credit
349.80
Notes Receivable
173.61
Other Equity Interest
-3,801.79
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
457.10
-8.88%
501.62
+0.36%
499.82
+83.25%
272.75
Cash Flow From Continuing Operating Activities
457.10
-8.88%
501.62
+0.36%
499.82
+83.25%
272.75
Net Income From Continuing Operations
-249.49
+62.42%
-663.90
-135.36%
-282.08
-793.20%
40.69
Depreciation Amortization Depletion
611.17
-15.39%
722.32
-6.90%
775.89
+62.40%
477.78
Depreciation
563.97
-16.47%
675.15
-7.60%
730.71
+61.28%
453.08
Amortization Cash Flow
47.20
+0.08%
47.16
+4.39%
45.18
+82.96%
24.70
Depreciation And Amortization
611.17
-15.39%
722.32
-6.90%
775.89
+62.40%
477.78
Amortization Of Intangibles
47.20
+0.08%
47.16
+4.39%
45.18
+82.96%
24.70
Other Non Cash Items
-24.83
+11.15%
-27.95
+18.39%
-34.25
-53.01%
-22.38
Stock Based Compensation
22.39
-29.65%
31.82
+122.73%
14.29
-29.77%
20.35
Asset Impairment Charge
364.60
-35.36%
564.08
+264.13%
154.91
+184.62%
54.43
Operating Gains Losses
-230.45
-110.68%
-109.38
-44.06%
-75.93
+71.58%
-267.18
Gain Loss On Investment Securities
-231.09
-110.55%
-109.75
-41.53%
-77.55
+71.31%
-270.27
Change In Working Capital
-57.80
-123.48%
-25.86
+63.52%
-70.89
-116.06%
-32.81
Change In Payables And Accrued Expense
-25.51
-590.73%
5.20
+127.69%
-18.77
-177.61%
24.19
Change In Other Current Assets
-31.46
+8.93%
-34.55
+38.25%
-55.95
-114.37%
-26.10
Change In Other Current Liabilities
-0.83
-123.77%
3.48
-8.96%
3.83
+112.38%
-30.91
Investing Cash Flow
710.83
-21.10%
900.92
+158.04%
349.14
-78.64%
1,634.36
Cash Flow From Continuing Investing Activities
710.83
-21.10%
900.92
+158.04%
349.14
-78.64%
1,634.36
Net PPE Purchase And Sale
-330.15
-32.60%
-248.98
-7.77%
-231.03
-41.26%
-163.54
Purchase Of PPE
-330.15
-32.60%
-248.98
-7.77%
-231.03
-41.26%
-163.54
Capital Expenditure
-330.15
-32.60%
-248.98
-7.77%
-231.03
-41.26%
-163.54
Net Investment Purchase And Sale
Purchase Of Investment
Net Business Purchase And Sale
-2.19
0.00
+100.00%
-3.82
-100.36%
1,059.87
Purchase Of Business
-2.19
0.00
+100.00%
-3.82
+96.17%
-99.97
Net Other Investing Changes
51.27
+6196.20%
-0.84
+96.91%
-27.21
-20.21%
-22.64
Financing Cash Flow
-1,210.67
+10.94%
-1,359.32
-53.73%
-884.22
+52.44%
-1,859.33
Cash Flow From Continuing Financing Activities
-1,210.67
+10.94%
-1,359.32
-53.73%
-884.22
+52.44%
-1,859.33
Net Issuance Payments Of Debt
-796.57
-112.14%
-375.49
+7.09%
-404.16
+11.61%
-457.23
Issuance Of Debt
1,449.00
+12.41%
1,289.00
+85.73%
694.00
-1.77%
706.50
Repayment Of Debt
-2,245.57
-34.91%
-1,664.49
-51.57%
-1,098.16
+5.63%
-1,163.73
Long Term Debt Issuance
1,449.00
+12.41%
1,289.00
+85.73%
694.00
-1.77%
706.50
Long Term Debt Payments
-2,245.57
-34.91%
-1,664.49
-51.57%
-1,098.16
+5.63%
-1,163.73
Net Long Term Debt Issuance
-796.57
-112.14%
-375.49
+7.09%
-404.16
+11.61%
-457.23
Net Short Term Debt Issuance
-385.00
-1062.50%
40.00
Net Common Stock Issuance
-4.01
+99.23%
-519.20
-23848.34%
-2.17
-111.00%
19.71
Common Stock Payments
-4.01
+99.23%
-519.30
-22498.09%
-2.30
+28.01%
-3.19
Common Stock Dividend Paid
-386.92
+15.49%
-457.85
+3.05%
-472.24
+66.44%
-1,407.36
Cash Dividends Paid
-386.92
+15.49%
-457.85
+3.05%
-472.24
+66.44%
-1,407.36
Repurchase Of Capital Stock
-4.01
+99.23%
-519.30
-22498.09%
-2.30
+28.01%
-3.19
Net Other Financing Charges
-23.17
-241.78%
-6.78
-19.96%
-5.65
+60.88%
-14.45
Changes In Cash
-42.74
-198.91%
43.22
+222.56%
-35.26
-173.79%
47.79
Beginning Cash Position
68.92
+168.17%
25.70
-57.84%
60.96
+362.70%
13.18
End Cash Position
26.17
-62.02%
68.92
+168.17%
25.70
-57.84%
60.96
Free Cash Flow
126.94
-49.75%
252.64
-6.01%
268.79
+146.14%
109.20
Interest Paid Supplemental Data
176.55
-12.82%
202.50
-6.26%
216.03
+91.70%
112.69
Common Stock Issuance
0.00
-100.00%
0.10
-20.00%
0.13
-99.43%
22.90
Dividend Received CFO
21.52
+104.94%
10.50
-41.29%
17.88
+850.56%
1.88
Earnings Losses From Equity Investments
0.19
+39.26%
0.14
-91.97%
1.68
+144.83%
0.69
Issuance Of Capital Stock
0.00
-100.00%
0.10
-20.00%
0.13
-99.43%
22.90
Net Investment Properties Purchase And Sale
991.90
-13.80%
1,150.74
+88.27%
611.21
-19.65%
760.68
Purchase Of Investment Properties
-12.72
+81.91%
-70.34
+22.05%
-90.23
+79.51%
-440.39
Sale Of Business
0.00
0.00
-100.00%
1,159.84
Sale Of Investment Properties
1,004.62
-17.73%
1,221.08
+74.08%
701.43
-41.60%
1,201.07
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category